Valeant Pharma (VRX) November weekly 19 straddle priced for movement of 17% into Q3
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Valeant Pharma (NYSE: VRX) November weekly 19 straddle priced for movement of 17% into Q3
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott (NYSE: ABT) weekly volatility elevated, into seeking to terminate acquisition of Alere
- Nu Skin Enterprises (NUS) weekly call implied volatility elevated into guiding FY17 EPS below views
- Options expected to have Increasing volume: SBUX HLT MU WDC AZO AMZN TWX T COST HRB LULU
Create E-mail Alert Related CategoriesOptions, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!